Skip to main content
An official website of the United States government
Email

170th Meeting of the National Cancer Advisory Board - Meeting Agenda

March 17, 2026

NIH Videocast: https://videocast-b.nih.gov/livew.asp?live=57308
Location: National Cancer Institute, Shady Grove Campus, Terrace Level, Conference Room TE 406

March 17 Agenda - Open Session
TimePresentation TopicPresenter
9:00 am - 9:05 am

Call to Order and Opening Remarks

  • Consideration of Meeting Summary:
    December 2, 2025, NCAB Meeting
  • Conflict of Interest
  • Future Meeting Dates

Confirmed Dates:
June 29-30, 2026 - Monday and Tuesday
September 2-3, 2026 - Wednesday and Thursday
December 1-2, 2026 - Tuesday and Wednesday

To Be Confirmed Dates:
February 11, 2027 - Thursday
June 9-10, 2027 - Wednesday, Thursday
September 1-2, 2027 - Wednesday, Thursday
December 1-2, 2027 - Wednesday, Thursday
February 10, 2028 - Thursday
June 7-8, 2028 - Wednesday, Thursday
September 13-14, 2028 - Wednesday, Thursday
December 5-6, 2028 - Tuesday, Wednesday

Dr. Carpten
9:05 am - 9:40 amNCI Director's ReportDr. Letai
9:40 am - 10:10 amBudget UpdateMr. Ricks
10:10 am - 10:25 amBreak
10:25 am - 10:55 amPresident's Cancer Panel ReportDr. Brown
10:55 am - 11:25 amNCI Cancer Centers Program UpdatesDr. Ptak
11:25 am - 12:05 pmScientific Presentation-Cancer VaccinesDr. Wu
12:05 pm - 1:05 pmLunch
1:05 pm - 1:45 pmScientific Presentation-Cancer Grand ChallengesDr. Kurtz
1:45 pm - 1:55 pmAnnual Delegations of AuthorityDr. Srinivas
1:55 pm - 2:10 pmNCI Community Oncology Research Program Bridge FundingDr. Heckman-Stoddard
2:10 pm - 2:20 pmBreak
2:20 pm - 3:00 pm

Ongoing and New Business - Dr. Carpten

Ad Hoc Work Group Report

  • Working Group on Extramural Research Concepts and Programs - Dr. Ulrich

Consideration of Public Comments
Future Agenda Items

 
3:00 pm - 3:10 pmBreak and Adjournment of Open Session
March 17 Agenda - Closed Session
TimePresentation TopicPresenter
3:10 pm - 5:00 pm

This portion of the meeting is being closed to the public in accordance with the Provisions set forth in Sections 552b(c) (4), 552b(c) (6). Title 5 U.S. Code and 10(d) of The Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2).

  • Grants Review
  • Discussions of Personnel and Proprietary Issues
5:00 pmAdjournment
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “170th Meeting of the National Cancer Advisory Board - Meeting Agenda was originally published by the National Cancer Institute.”

Email